Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Cystadenocarcinoma, Papillary

medroxyprogesterone acetate has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCartney, AJ; Williams, K; Woolas, RP1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Cystadenocarcinoma, Papillary

ArticleYear
Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
    Gynecologic oncology, 1994, Volume: 52, Issue:3

    Topics: Adult; Cystadenocarcinoma, Papillary; Female; Humans; Medroxyprogesterone Acetate; Turner Syndrome; Uterine Neoplasms

1994